With years of experience in the field of anti-virus biomolecular discovery, Creative Biolabs has become a world-leading service provider skilled in providing the first-in-class service for the discovery of antibody and peptide targeting EV71. Based on our Anti-Virus Biomolecular Discovery platform, we guarantee high-quality services in a cost- and time-efficient manner.